Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

United States considers drug stockpile.

Woodward C.

CMAJ. 2011 Nov 8;183(16):E1171-2. doi: 10.1503/cmaj.109-4018. Epub 2011 Oct 11. No abstract available.

2.

America's drug problem.

Philpott S.

Hastings Cent Rep. 2012 Jul-Aug;42(4):9-10. doi: 10.1002/hast.59. No abstract available.

PMID:
22777971
3.

Improving access to medicines in poor countries: the role of universities.

Chokshi DA.

PLoS Med. 2006 Apr;3(6):e136. No abstract available.

4.

Pharmaceuticals and the strategic national stockpile program.

Stewart A, Cordell GA.

Dent Clin North Am. 2007 Oct;51(4):857-69, vii.

PMID:
17888762
5.

Drug prices may be too high despite WTO deal.

Fleck F.

Bull World Health Organ. 2003;81(10):774-5. Epub 2003 Nov 25. No abstract available.

6.

Patents and access to essential drugs.

Loff B.

Trans R Soc Trop Med Hyg. 2003 Jan-Feb;97(1):6-9.

PMID:
12886793
7.
8.

Access to essential drugs, human rights and global justice.

Shalev C.

Monash Bioeth Rev. 2004 Jan;23(1):S56-74. No abstract available.

PMID:
15835024
9.

Drug shortage crisis affects patients and nurses.

Carter D.

Am J Nurs. 2011 Nov;111(11):14. doi: 10.1097/01.NAJ.0000407289.24878.32. No abstract available.

PMID:
22030911
10.

When doses disappear. Flu shot shortage sheds light on drug supply chain.

Becker C.

Mod Healthc. 2004 Oct 18;34(42):16. No abstract available.

PMID:
15552188
11.

Eliminating neglected diseases: impact of published paper.

Brownback S.

Health Aff (Millwood). 2007 Sep-Oct;26(5):1509. No abstract available.

PMID:
17848471
12.

TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.

't Hoen E.

Chic J Int Law. 2002 Spring;3(1):27-46. No abstract available.

PMID:
15709298
13.

Action on Canada's generic drug law.

Abi-Jaoude E.

CMAJ. 2004 Apr 27;170(9):1374; author reply 1374-5. No abstract available.

14.

Access to essential drugs prevented by pharmaceutical multinationals.

[No authors listed]

Dev World Bioeth. 2001 May;1(1):1-6. No abstract available.

PMID:
12870503
15.

The shortage of essential chemotherapy drugs in the United States.

Gatesman ML, Smith TJ.

N Engl J Med. 2011 Nov 3;365(18):1653-5. doi: 10.1056/NEJMp1109772. Epub 2011 Oct 31. No abstract available. Erratum in: N Engl J Med. 2011 Dec 22;365(25):2441.

16.

The global drug gap.

Reich MR.

Science. 2000 Mar 17;287(5460):1979-81.

PMID:
10755953
17.

Drugs and vaccines around the world.

[No authors listed]

Health Aff (Millwood). 2006 Mar-Apr;25(2):312. No abstract available.

PMID:
16522572
18.

ASHP guidelines on managing drug product shortages.

ASHP Council on Administrative Affairs, American Society of Health-System Pharmacists.

Am J Health Syst Pharm. 2001 Aug 1;58(15):1445-50. No abstract available.

PMID:
11494791
19.

Drug donations: what lies beneath.

Pinheiro CP.

Bull World Health Organ. 2008 Aug;86(8):580-A. No abstract available.

20.

EU launches measures to stop diversion of cut-price drugs.

Fleck F.

Bull World Health Organ. 2003;81(7):549. Epub 2003 Sep 3. No abstract available.

Supplemental Content

Support Center